MCM
PGNX

Manchester Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Manchester Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,020
Closed -$14K – 674
2019
Q1 		$14K Buy
+3,020
New +$14K ﹤0.01% 541